What three companies are dominating China's mHealth market?

By Admin
Today, Chinas mHealth market is estimated to be worth 1.8 billion RMB, or $291 million in the U.S., and is expected to expand to reach 12.5 billion by 2...

Today, China’s mHealth market is estimated to be worth 1.8 billion RMB, or $291 million in the U.S., and is expected to expand to reach 12.5 billion by 2017. This 600 percent increase will come from breakthroughs in mHealth technology, wearables and health IT companies, like Cerner, McKesson and Epic.

As home to over 1.3 billion people, China’s healthcare sector is one that needs immediate attention and immediate investments in order to accommodate its patients’ futures. This ever-increasing demand for EMR technology, EHR, healthcare apps and healthcare IT services is set to increase by 19 percent in this year alone— marking the beginning of a long-lasting Chinese healthcare trend.

The following are the Top 3 Chinese mHealth companies to watch in 2014:

1. Microsoft and IBM pull ahead in China

These two U.S. powerhouses have managed to begin their expansion into Chinese markets, in response to a $124 billion, three-year healthcare reform plan from China’s Ministry of Health.

Microsoft has begun bracing Chinese hospitals with smart technology through the integration of EMRs, patient and bed management, laboratory data, and other patient-related data in cloud-based, real-time solutions. Microsoft has enlisted the company HealthVault to manage this integration process, in order to tie into its own EHR system as well.

IBM has installed new technology in a group of hospitals in the Guangzhou to standardize EMRs, using the collected data to statistically analyze Chinese medical treatments alongside traditional Chinese ones. This kind of accommodating technology has resonated well with the Chinese people, and they are quickly investing more in IBM’s culture-friendly procedures.

2. Apple iOS is not China’s ideal platform

In the U.S. Apple is by far the platform of choice, absorbing 43 percent of the market’s cell phones and 34 percent of the tablet market. However, in China, Apple only controls about 17 percent of the smartphone realm and 28 percent of the tablet market. This kind of comparison demonstrates just how unfavorable apples iOS capabilities in the Chinese market, and how this lapse in monopoly translates in big opportunities for investment and capitalization from its competitors.

Forbes reported that, “With IBM and Microsoft building smarter hospitals from the ground up across China, there will be less demand for native iPad EMR/EHR apps in hospitals, which were created as a response to outdated technologies in the U.S. Meanwhile, consumer-focused app developers are more likely to create health-related apps for Android to reach a wider audience.”

3. Lenovo and Microsoft becoming Chinese favorites

In order to see why Lenovo and Microsoft are huge potential investment opportunities, one needs to analyze both companies respective attempts at embracing Chinese demographics and the long-term company goals. The Motley Fool broke down the companies advantages best by listing them in the following way:

  • “Many of Lenovo's recent laptops are hybrid devices with removable tablets.
  • Most of these devices run Windows 8/8.1, which will gain market share in hospitals thanks to Microsoft's early expansion into Chinese health care IT with HealthVault.
  • Windows 8/8.1 devices are popular in hospitals, since the same EMR/EHR program can be run in both a desktop and bedside (mobile) setting, especially if the device is a hybrid with a detachable tablet.
  • Lenovo also controls 11.8% of China's fragmented smartphone market with its Android devices, putting it in third place behind Samsung and Apple. That share is poised to rise after its acquisition of Motorola earlier this year.”
Share

Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance